SECFilingvia Quantisnow
Telix Pharmaceuticals Limited logo

TLX: SEC Form 6-K filed by Telix Pharmaceuticals Limited

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Full content unavailable. See the original source below.

Historical context for TLX

Across the 28 sessions after earlier TLX headlines, the stock closed higher 18 times and lower 10 times, with a median move of 2.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

Keep researching TLX

Quantisnow market dataNASDAQ
Telix Pharmaceuticals Limited logo
TLX
Telix Pharmaceuticals Limited
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for TLX

Follow TLX and get a push notification the moment its next story breaks.

Full TLX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TLX (Telix Pharmaceuticals Limited) and more on Quantisnow.